Zebrafish as an alternative model for hypoxic-ischemic brain damage

International Journal of Physiology, Pathophysiology and Pharmacology

Volumn 3, Issue 2, 2011, Pages 88-96

  Yu, Xinge ^a   Li, Yang V ^a  

^a OHIO UNIVERSITY   (United States)

Author keywords

Animal model; Brain injury; Ischemia; Stroke; Triphenyltetrazolium; Zebrafish

Indexed keywords

TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALANCE DISORDER; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; COORDINATION; DISEASE MODEL; HYPOXIA; NONHUMAN; OPTIC LOBE; OXYGEN CONCENTRATION; SWIMMING; ZEBRA FISH;

EID: 79960124026     PISSN: None     EISSN: 19448171     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Lu-Emerson C, Khot S: Neurological sequelae of hypoxic-ischemic brain injury. NeuroRehabilitation, 26:35-45.
2. Cheng YD, Al-Khoury L, Zivin JA: Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx 2004, 1:36-45.
3. Marler JR: NINDS clinical trials in stroke: lessons learned and future directions. Stroke 2007, 38:3302-3307.
4. Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M: Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Stroke 2009, 40:2594-2600.
5. Durukan A, Tatlisumak T: Animal models of ischemic stroke. Handb Clin Neurol 2009, 92:43-66.
6. Fisher M, Tatlisumak T: Use of animal models has not contributed to development of acute stroke therapies: con. Stroke 2005, 36:2324-2325.
7. Kaste M: Use of animal models has not contributed to development of acute stroke therapies: pro. Stroke 2005, 36:2323-2324.
8. Mergenthaler P, Dirnagl U, Meisel A: Pathophysiology of stroke: lessons from animal models. Metab Brain Dis 2004, 19:151-167.
9. Richard Green A, Odergren T, Ashwood T: Animal models of stroke: do they have value for discovering neuroprotective agents? Trends Pharmacol Sci 2003, 24:402-408.
10. Lieschke GJ, Currie PD: Animal models of human disease: zebrafish swim into view. Nat Rev Genet 2007, 8:353-367.
11. Amatruda JF, Patton EE: Genetic models of cancer in zebrafish. Int Rev Cell Mol Biol 2008, 271:1-34.
12. Biga PR, Goetz FW: Zebrafish and giant danio as models for muscle growth: determinate vs. indeterminate growth as determined by morphometric analysis. Am J Physiol Regul Integr Comp Physiol 2006, 291:R1327-1337.
13. Gross JM, Perkins BD: Zebrafish mutants as models for congenital ocular disorders in humans. Mol Reprod Dev 2008, 75:547-555.
14. Panula P, Sallinen V, Sundvik M, Kolehmainen J, Torkko V, Tiittula A, Moshnyakov M, Podlasz P: Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases. Zebrafish 2006, 3:235-247.
15. Steenbergen PJ, Richardson MK, Champagne DL: The use of the zebrafish model in stress research. Prog Neuropsychopharmacol Biol Psychiatry.
16. Kokel D, Bryan J, Laggner C, White R, Cheung CY, Mateus R, Healey D, Kim S, Werdich AA, Haggarty SJ, et al: Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol, 6:231-237.
17. Piato AL, Capiotti KM, Tamborski AR, Oses JP, Barcellos LJ, Bogo MR, Lara DR, Vianna MR, Bonan CD: Unpredictable chronic stress model in zebrafish (Danio rerio): Behavioral and physiological responses. Prog Neuropsychopharmacol Biol Psychiatry.
18. McGrath P, Li CQ: Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov Today 2008, 13:394-401.
19. Hill AJ, Teraoka H, Heideman W, Peterson RE: Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 2005, 86:6-19.
20. Eimon PM, Rubinstein AL: The use of in vivo zebrafish assays in drug toxicity screening. Expert Opin Drug Metab Toxicol 2009, 5:393-401.
21. Zon LI, Peterson R: The new age of chemical screening in zebrafish. Zebrafish, 7:1.
22. Ou HC, Santos F, Raible DW, Simon JA, Rubel EW: Drug screening for hearing loss: using the zebrafish lateral line to screen for drugs that prevent and cause hearing loss. Drug Discov Today, 15:265-271.
23. Hao J, Williams CH, Webb ME, Hong CC: Large scale zebrafish-based in vivo small molecule screen. J Vis Exp.
24. George S, Xia T, Rallo R, Zhao Y, Ji Z, Lin S, Wang X, Zhang H, France B, Schoenfeld D, et al: Use of a High-Throughput Screening Approach Coupled with In Vivo Zebrafish Embryo Screening To Develop Hazard Ranking for Engineered Nanomaterials. ACS Nano.
25. Faulk CK, Holt GJ: Responses of cobia Rachycentron canadum larvae to abrupt or gradual changes in salinity. Aquaculture 2006,254:275-283.
26. National Science and Technology Council (U.S.). Committee on Environment and Natural Resources.: Integrated assessment of hypoxia in the northern Gulf of Mexico. [Washington, D.C.]: National Science and Technology Council, Committee on Environment and Natural Resources; 2000.
27. Isayama K, Pitts LH, Nishimura MC: Evaluation of 2,3,5-triphenyltetrazolium chloride staining to delineate rat brain infarcts. Stroke 1991,22:1394-1398.
28. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM: Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986, 17:1304-1308.
29. Hobbs JP, McDonald CA: Increased seawater temperature and decreased dissolved oxygen triggers fish kill at the Cocos (Keeling) Islands, Indian Ocean. J Fish Biol, 77:1219-1229.
30. Lippold HJ: Quantitative succinic dehydrogenases histochemistry. A comparison of different tetrazolium salts. Histochemistry 1982, 76:381-405.
31. Allner B, von der Gonna S, Griebeler EM, Nikutowski N, Weltin A, Stahlschmidt-Allner P: Reproductive functions of wild fish as bioindicators of reproductive toxicants in the aquatic environment. Environ Sci Pollut Res Int, 17:505-518.
32. Kolok AS: Sublethal identification of susceptible individuals: using swim performance to identify susceptible fish while keeping them alive. Ecotoxicology 2001, 10:205-209.
33. Bacigaluppi M, Comi G, Hermann DM: Animal models of ischemic stroke. Part two: modeling cerebral ischemia. Open Neurol J, 4:34-38.
34. Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM, Arumugam TV: Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener, 6:11.
35. Kirino T, Sano K: Selective vulnerability in the gerbil hippocampus following transient ischemia. Acta Neuropathol 1984, 62:201-208.
36. Allison WT: Preface: zebrafish models of neurology. Biochim Biophys Acta, 1812:333-334.
37. Liu S, Leach SD: Zebrafish models for cancer. Annu Rev Pathol, 6:71-93.
38. Rihel J, Prober DA, Arvanites A, Lam K, Zimmerman S, Jang S, Haggarty SJ, Kokel D, Rubin LL, Peterson RT, Schier AF: Zebrafish